Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

The global pacemakers market, valued at USD 4.4 billion in 2020, is anticipated to grow to USD 5.4 billion by 2027, at a CAGR of 3.0% during the forecast period (2021-2027). This growth is primarily ...

Fourth quarter revenue up 16% year-over-year, $26.9M of secured debt eliminated, and total cash and escrowed proceeds of $44.3M at ...

The draw: a conference called “Mass Torts Made Perfect,” held in the hotel’s grand ballroom, tucked well behind its famous ...

Boston Scientific, which is growing in Minnesota, is buying California’s Penumbra for $14.5 billion. CEO Mike Mahoney said ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Boston Scientific is capping off a busy week with a major buyout, entering a deal worth about $14.5 billion to acquire ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes products used in minimally invasive procedures to treat conditions such as ...

Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping ...